Strattera, Atomoxetine Hydrochloride Newswire

Strattera, Atomoxetine Hydrochloride Newswire

Comprehensive Real-Time News Feed for Strattera, Atomoxetine Hydrochloride (generic).

Results 1 - 20 of 20 in Strattera, Atomoxetine Hydrochloride (generic)

  1. Cheapest Generic Strattera Pills Order a " Fast ShippingRead the original story

    Sunday Nov 27 | Hernando Today

    Order Cheap Strattera without prescription. Generic Strattera is used to treat attention deficit hyperactivity disorder .

    Comment?

  2. Is Eli Lilly A Buy After Their Recent Clinical Failure?Read the original story w/Photo

    Sunday Nov 27 | Seeking Alpha

    The research-based drug industry is rife with numerous failures. The process of bringing forth novel compounds is particularly perilous as adverse events may crop up scuttling the commercial viability of the product deep into phase three testing.

    Comment?

  3. Best Rated Online Pharmacy Discount Atomoxetine Guaranteed ShippingRead the original story

    Friday Nov 25 | Hernando Today

    Best Place To Order Strattera Pills. Generic Strattera is used to treat attention deficit hyperactivity disorder .

    Comment?

  4. Recent Research Analysts' Ratings Changes for Eli Lilly andRead the original story w/Photo

    Friday Nov 4 | AmericanBankingNews.com

    They now have a $100.00 price target on the stock, down previously from $105.00. 10/27/2016 - Eli Lilly and had its "hold" rating reaffirmed by analysts at Societe Generale.

    Comment?

  5. Strattera Drug Market 2016 Overview, Properties & DevelopmentRead the original story

    Thursday Nov 3 | Emailwire.com

    ReportsWeb.com published 'Strattera Drug Market' from its database. The report covers the market landscape and its growth prospects over the coming years.

    Comment?

  6. These companies also used lobbyists who doubled as Clinton campaign fundraisersRead the original story w/Photo

    Oct 16, 2016 | USA Today

    Here are other companies that USA TODAY's review found contributed to the Clinton-family nonprofits and lobbied Hillary Clinton's State Department with lobbyists who doubled as Clinton campaign supporters and fundraisers. These companies also used lobbyists who doubled as Clinton campaign fundraisers Here are other companies that USA TODAY's review found contributed to the Clinton-family nonprofits and lobbied Hillary Clinton's State Department with lobbyists who doubled as Clinton campaign supporters and fundraisers.

    Comment?

  7. Supernus - SPN-812 Results And Thesis UpdateRead the original story w/Photo

    Oct 14, 2016 | Seeking Alpha

    Supernus reported positive phase 2b trial results of SPN-812 in children with ADHD. The results were statistically significant and the effect size, safety, and tolerability could make '812 a non-stimulant market leader in the ADHD market.

    Comment?

  8. Eli Lilly's Future Is ChangingRead the original story w/Photo

    Aug 30, 2016 | GuruFocus.com

    The company's total dividends paid have increased from 4.55 cents per share in 1972 to a projected $2.04 per share in fiscal year 2016. Should investors be concerned that Eli Lilly could be poised for years of flat dividends or possibly even a cut to the dividend? Eli Lilly is a global pharmaceutical company with an operating history that dates back to the late 1800s.

    Comment?

  9. Investment Analysts' Upgrades for July, 29thRead the original story w/Photo

    Jul 29, 2016 | AmericanBankingNews.com

    The firm currently has $192.00 target price on the stock. According to Zacks, "Amgen's Q2 results were impressive with the company topping on both earnings and revenues.

    Comment?

  10. Fitch Affirms Eli Lilly's IDR at 'A'; Outlook StableRead the original story w/Photo

    Jul 22, 2016 | Reuters

    CHICAGO, July 22 Fitch Ratings has affirmed Eli Lilly & Co. Inc.'s Long-Term Issuer Default Rating at 'A' with a Stable Outlook.

    Comment?

  11. No increase in heart attack, stroke risk seen with ADHD medsRead the original story w/Photo

    Jul 7, 2016 | CNN

    The million-plus U.S. adults who take medication for attention deficit hyperactivity disorder do not appear to be increasing their risk of heart attack or stroke, as some experts have feared, according to a new study published today on the website of the Journal of the American Medical Association. Stimulant medications -- a class that includes Ritalin, Adderall, Concerta, and their generic versions -- and the non-stimulant drug Strattera have all been shown to slightly raise blood pressure and heart rate, which can contribute to heart problems.

    Comment?

  12. UB Research Pharmacy open to assist WNY faculty, scientists with clinical trialsRead the original story

    Jul 1, 2016 | Grand Island Pennysaver

    For researchers hoping to provide medication to their study participants during clinical trials, sorting through the myriad regulations can be a headache. Luckily, the Research Pharmacy within the University at Buffalo School of Pharmacy and Pharmaceutical Sciences is a call away, providing services that range from compounding custom medications and providing clinical patient services to dispensing complex medication regimens.

    Comment?

  13. UB Research Pharmacy open to assist WNY faculty, scientists with clinical trialsRead the original story

    Jun 30, 2016 | University at Buffalo

    "Together with our health care partners, we can improve research in health care by expanding the knowledge base within our local and regional communities." BUFFALO, N.Y. For researchers hoping to provide medication to their study participants during clinical trials, sorting through the myriad of regulations can be a headache.

    Comment?

  14. Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical...Read the original story

    Jun 21, 2016 | Freshnews

    Neurotrope, Inc. : today announced that Paula T. Trzepacz, M.D., has joined Neurotrope BioScience, Inc., the Company's wholly owned operating subsidiary, as its Executive Vice President and Chief Medical Officer. Prior to joining Neurotrope, Dr. Trzepacz was at Eli Lilly and Company for over 15 years where she was most recently a Senior Medical Fellow in Neurosciences drug development.

    Comment?

  15. Neurotrope Taps Former Eli Lilly Exec as New CMORead the original story

    Jun 20, 2016 | BioSpace

    Prior to joining Neurotrope, Dr. Trzepacz was at Eli Lilly and Company for over 15 years where she was most recently a Senior Medical Fellow in Neurosciences drug development. She served on the global drug development team for Amyvid, the PET radiotracer indicated for estimation of beta-amyloid plaque density in brains of cognitively impaired persons suspected of having Alzheimer's disease.

    Comment?

  16. KemPharm's Best Strategy - Manage Risk By Reordering KP415, KP511, And KP201/IRRead the original story w/Photo

    Jun 16, 2016 | Seeking Alpha

    Investors desperately need more clarity regarding the discussions around Apadaz, as the market is currently pricing in no chance of Apadaz approval. KP511 or KP415 might present a less risky and potentially larger opportunity than the current next drug up for an NDA filing, KP201/IR.

    Comment?

  17. Medication may need adjustmentRead the original story w/Photo

    May 31, 2016 | The Guardian

    Dear Dr. Wong: Our son is in Grade 4. He was diagnosed with ADHD more than a year ago. He couldn't pay attention in school and disrupted the class.

    Comment?

  18. Teens with ADHD have special treatment needsRead the original story

    May 10, 2016 | Reuters

    Both stimulants and alternative medications can help reduce symptoms such as restlessness, forgetfulness and lack of motivation, the study found. Psychotherapy that addresses issues like behavior, organization and social skills may not always ease symptoms but can result in better school performance, the study also found.

    Comment?

  19. Better Buy: AbbVie Inc. vs. Eli LillyRead the original story w/Photo

    Mar 18, 2016 | The Motley Fool

    Spun off from Abbott Laboratories in 2013, from a certain point of view AbbVie is an infant. Eli Lilly's primary focus has been pharmaceuticals since the 19th century.

    Comment?

  20. ADHD meds linked to lower bone density in kidsRead the original story w/Photo

    Mar 4, 2016 | Examiner.com

    Children and adolescents who take medication for attention-deficit/hyperactivity disorder may be at a higher risk for decreased bone density , according to new research. The study, presented March 3 at the 2016 Annual Meeting of the American Academy of Orthopedic Surgeons in Orlando, included the use of Ritalin, Dexedrine, Focalin, Strattera and Vyvanse.

    Comment?